XBiotech Inc.
Organization details
- Legal name
- XBiotech Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- British Columbia, Canada
- Headquarters city
- Austin
- Headquarters state / province
- Texas
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- XBIT
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001626878
Board of directors
-
Craig Evan Rademaker · DirectorSince 2025
-
David Spencer Soffer · DirectorSince 2025
-
Donald H. MacAdam · DirectorSince 2023
-
Jan-Paul Waldin · DirectorSince 2023
-
John Simard · Director · Chief Executive OfficerSince 2024
-
Peter Libby · DirectorSince 2023
-
Tevi David Troy · DirectorSince 2025
-
Thomas Martin Kuendig · DirectorSince 2025
-
W. Thorpe Mckenzie · DirectorSince 2023
Chief executives
Director election results
Annual meeting of August 29, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
95.6%
-
95.6%
-
96.2%
-
97.2%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $854,660
- 2 purchases by 1 insider
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 3, 2026 | John Simard Director, 10% owner | Open-market purchase | +70,000 | $2.05 | $143,409 |
| Oct 26, 2026 | John Simard Director, 10% owner | Open-market purchase | +368,524 | $1.93 | $711,251 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about XBiotech Inc.
Who is the CEO of XBiotech Inc.?
John Simard is XBiotech Inc.'s Chief Executive Officer.
How many directors are on XBiotech Inc.'s board?
XBiotech Inc.'s board has 9 directors: Craig Evan Rademaker, David Spencer Soffer, Donald H. MacAdam, Jan-Paul Waldin, John Simard, Peter Libby, Tevi David Troy, Thomas Martin Kuendig and W. Thorpe Mckenzie.
Are XBiotech Inc. insiders buying or selling shares?
Over the last 12 months, XBiotech Inc. insiders bought $854,660 of shares in 2 purchases and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="xbiotech-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.